Psychopharmacology in the Elderly: Why Does Age Matter?
Title
Psychopharmacology in the Elderly: Why Does Age Matter?
Creator
Kripa Balaram
Date
2022
Description
A growing percentage of the population is aging, with a large subset of this group meeting criteria for one or more neuropsychiatric disorders. Generally, physiological changes due to aging affect most of the pharmacokinetic processes in the body, with age-related physiologic changes in cardiovascular, gastric, hepatic, and renal function leading to changes in the pharmacokinetics of medications that can affect the absorption, distribution, accumulation, and clearance and elimination of various medications. This article aims to discuss the common pharmacodynamic and pharmacokinetic changes associated with physiologic aging and their impacts on the use of psychotropic medications in the elderly.
Source
Psychiatr Clin North Am
. 2022 Dec;45(4):735-744. doi: 10.1016/j.psc.2022.07.004. Epub 2022 Oct 14.
. 2022 Dec;45(4):735-744. doi: 10.1016/j.psc.2022.07.004. Epub 2022 Oct 14.
Language
English
URL
https://doi.org/10.1016/j.psc.2022.07.004
Citation
Kripa Balaram, “Psychopharmacology in the Elderly: Why Does Age Matter?,” NEOMED Bibliography Database, accessed April 27, 2024, https://neomed.omeka.net/items/show/11982.